Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KZR
1951
DELISTED
Kezar Life Sciences
KZR
| $1.38K | ﹤0.01% |
56
-3,784
| -99% | -$98.5K |
|
1952
Agilysys
AGYS
$3.21B
| $1.31K | ﹤0.01% |
+19
| New | +$1.43K |
|
1953
Li Auto
LI
$12.2B
| $1.3K | ﹤0.01% |
+37
| New | +$1.04K |
|
|
LUCK
1954
Lucky Strike Entertainment
LUCK
$915M
| $1.23K | ﹤0.01% |
+106
| New | +$1.41K |
|
1955
Northwest Natural Holdings
NWN
$2.11B
| $1.23K | ﹤0.01% |
29
-4,755
| -99% | -$215K |
|
1956
AEye
LIDR
$56.3M
| $1.17K | ﹤0.01% |
+216
| New | +$1.34K |
|
1957
Hanmi Financial
HAFC
$926M
| $1.17K | ﹤0.01% |
+78
| New | +$1.25K |
|
|
RDUS
1958
DELISTED
Radius Recycling
RDUS
| $1.11K | ﹤0.01% |
+37
| New | +$1.11K |
|
|
SCS
1959
DELISTED
Steelcase
SCS
| $1.11K | ﹤0.01% |
+144
| New | +$1.09K |
|
1960
IMAX
IMAX
$3B
| $1.06K | ﹤0.01% |
+62
| New | +$1.18K |
|
|
VRAY
1961
DELISTED
ViewRay, Inc.
VRAY
| $1.01K | ﹤0.01% |
2,873
-11,671
| -80% | -$12.1K |
|
1962
STAAR Surgical
STAA
$1.17B
| $1.01K | ﹤0.01% |
+19
| New | +$1.16K |
|
|
KORE
1963
DELISTED
KORE Group Holdings
KORE
| $956 | ﹤0.01% |
+157
| New | +$1.04K |
|
1964
MillerKnoll
MLKN
$1.58B
| $911 | ﹤0.01% |
62
-2,203
| -97% | -$35.2K |
|
1965
Federal Agricultural Mortgage
AGM
$2.38B
| $862 | ﹤0.01% |
+6
| New | +$823 |
|
1966
American Vanguard Corp
AVD
$64M
| $858 | ﹤0.01% |
48
-3,339
| -99% | -$61.7K |
|
1967
GoPro
GPRO
$111M
| $818 | ﹤0.01% |
198
-177,402
| -100% | -$761K |
|
1968
Myriad Genetics
MYGN
$292M
| $816 | ﹤0.01% |
+35
| New | +$764 |
|
1969
SunCoke Energy
SXC
$816M
| $803 | ﹤0.01% |
102
-5,268
| -98% | -$41.4K |
|
1970
Shutterstock
SSTK
$198M
| $779 | ﹤0.01% |
16
-699
| -98% | -$39.9K |
|
1971
Latham Group
SWIM
$824M
| $750 | ﹤0.01% |
202
-14,790
| -99% | -$45.2K |
|
1972
Enact Holdings
ACT
$6.84B
| $742 | ﹤0.01% |
30
-23,470
| -100% | -$573K |
|
|
MMAT
1973
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $738 | ﹤0.01% |
34
-2,272
| -99% | -$54.6K |
|
1974
HealthStream
HSTM
$842M
| $737 | ﹤0.01% |
30
-516
| -95% | -$12.8K |
|
1975
Pediatrix Medical
MD
$2.16B
| $725 | ﹤0.01% |
+51
| New | +$716 |
|
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.